Ronald S. Walters

4.6k total citations · 1 hit paper
75 papers, 3.5k citations indexed

About

Ronald S. Walters is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ronald S. Walters has authored 75 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 22 papers in Hematology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ronald S. Walters's work include Cancer Treatment and Pharmacology (22 papers), Acute Myeloid Leukemia Research (15 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Ronald S. Walters is often cited by papers focused on Cancer Treatment and Pharmacology (22 papers), Acute Myeloid Leukemia Research (15 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Ronald S. Walters collaborates with scholars based in United States, United Kingdom and Australia. Ronald S. Walters's co-authors include Michael J. Keating, Emil J. Freireich, Gabriel N. Hortobágyi, Aman U. Buzdar, Kenneth B. McCredie, Hagop M. Kantarjian, Richard L. Theriault, Debra Frye, Frankie A. Holmes and Moshe Talpaz and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ronald S. Walters

75 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE IMPACT OF NATIONAL CANCER ACT

1991 712 citations Frankie A. Holmes, Ronald S. Walters et al. profile →

Peers

Countries citing papers authored by Ronald S. Walters

Since Specialization

Citations

This map shows the geographic impact of Ronald S. Walters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald S. Walters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald S. Walters more than expected).

Fields of papers citing papers by Ronald S. Walters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald S. Walters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald S. Walters. The network helps show where Ronald S. Walters may publish in the future.

Co-authorship network of co-authors of Ronald S. Walters

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald S. Walters. A scholar is included among the top collaborators of Ronald S. Walters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald S. Walters. Ronald S. Walters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	National Quality Forum Guidelines for Evaluating the Scientific Acceptability of Risk-adjusted Clinical Outcome Measures 2019 ·Annals of Surgery ·Laurent G. Glance, Karen E. Joynt Maddox, Karen Johnson, David R. Nerenz, David Cella, Bijan J. Borah, (unknown), Paul Kurlansky, Jennifer Perloff, Michael A. Stoto, Ronald S. Walters, Susan White, Zhenqiu Lin	19
2	Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature 2014 ·Journal of Cancer ·(unknown), Marwan Ghosn, Vicente Valero, Ronald S. Walters, Banu Arun, James L. Murray, Richard L. Theriault, Debbie Frye, Nuhad K. Ibrahim	4
3	The implications of the 2010 patient protection and affordable care act and the health care and education reconciliation act on cancer care delivery 2010 ·Cancer ·(unknown), (unknown), Thomas W. Feeley, Ronald S. Walters, (unknown), (unknown), Thomas W. Burke	40
4	Potential impact of tumor registry rule changes for recording inflammatory breast cancer 2010 ·Cancer ·Sarah Taylor, Ronald S. Walters	5
5	Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer 2008 ·Cancer ·Edgardo Rivera, Jaime Mejia, Banu Arun, (unknown), Ronald S. Walters, Abenaa M. Brewster, Kristine Broglio, Guosheng Yin, Bita Esmaeli, Gabriel N. Hortobágyi, Vicente Valero	81
6	Phase I–II Vinorelbine (Navelbine®) by Continuous Infusion in Patients with Metastatic Breast Cancer: Cumulative Toxicities Limit Dose Escalation 2001 ·Cancer Investigation ·Nuhad K. Ibrahim, Vicente Valero, Zia Ur Rahman, Richard L. Theriault, Ronald S. Walters, Aman U. Buzdar, Daniel J. Booser, Frankie A. Holmes, James L. Murray, Jie Willey, Robert C. Bast, Gabriel N. Hortobágyi	7
7	Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy 2000 ·Cancer ·Edgardo Rivera, Frankie A. Holmes, (unknown), Vicente Valero, Richard L. Theriault, Daniel J. Booser, Ronald S. Walters, Aman U. Buzdar, Kapil Dhingra, Giuseppe Fraschini, Gabriel N. Hortobagyi	15
8	Continuous-Infusion High-Dose Leucovorin With 5-Fluorouracil and Cisplatin for Relapsed Metastatic Breast Cancer: A Phase II Study 2000 ·American Journal of Clinical Oncology ·Daniel J. Booser, Ronald S. Walters, Frankie A. Holmes, Gabriel N. Hortobágyi	5
9	Phase II Study of Ifosfamide and Mesna in Patients With Metastatic Breast Cancer 1998 ·American Journal of Clinical Oncology ·Ronald S. Walters, Frankie A. Holmes, (unknown), (unknown), Gabriel N. Hortobagyi	6
10	A phase II study of CI-973 [SP-4-3(R)]- [1, 1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N′) platinum in patients with refractory advanced breast cancer 1996 ·Cancer Chemotherapy and Pharmacology ·Richard L. Theriault, Ronald S. Walters, Frankie A. Holmes, (unknown), C D Kowal, Gabriel N. Hortobágyi	8
11	Mediastinitis Related to Probable Central Vinblastine Extravasation in a Woman Undergoing Adjuvant Chemotherapy for Early Breast Cancer 1996 ·American Journal of Clinical Oncology ·Clay M. Anderson, Ronald S. Walters, Gabriel N. Hortobágyi	18
12	A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma 1992 ·Cancer ·Ronald S. Walters, Debra Frye, Aman U. Buzdar, Frankie A. Holmes, Gabriel N. Hortobágyi	18
13	Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer 1992 ·Investigational New Drugs ·John A. Benvenuto, Robert A. Newman, Gary S. Bignami, T. J. G. Raybould, Martin N. Raber, (unknown), Ronald S. Walters	30
14	Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia 1989 ·Cancer ·(unknown), Michael J. Keating, Ronald S. Walters, Charles Koller, Kenneth B. McCredie, Emil J. Freireich	47
15	Mitoxantrone-induced DNA damage in leukemia cells is enhanced by treatment with high-dose arabinosylcytosine 1988 ·Cancer Chemotherapy and Pharmacology ·Volker Heinemann, David Murray, Ronald S. Walters, Raymond E. Meyn, William Plunkett	24
16	The Role of Autologous Bone Marrow Transplantation in Acute Leukemiaa 1987 ·Annals of the New York Academy of Sciences ·Karel A. Dicke, Sundar Jagannath, Ronald S. Walters, Leonard Horwitz, Gary Spitzer	4
17	Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemia 1987 ·British Journal of Haematology ·Razelle Kurzrock, Mordechai Shtalrid, J. U. Gutterman, Charles Koller, Ronald S. Walters, José M. Trujillo, Moshe Talpaz	29
18	Chronic myelogenous leukemia in blast crisis 1987 ·The American Journal of Medicine ·Hagop M. Kantarjian, Michael J. Keating, Moshe Talpaz, Ronald S. Walters, (unknown), Ann Cork, K. B. McCredie, Emil J. Freireich	221
19	Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron 1987 ·Cancer ·Ronald S. Walters, (unknown), Michael J. Keating, Moshe Talpaz, Craig C. Childs, K. B. McCredie, E. J. Freireich	21
20	Comparison of Results of Salvage Therapy in Adult Acute Myelogenous Leukemia 1987 ·Acta Haematologica ·Michael J. Keating, Elihu H. Estey, (unknown), Ronald S. Walters, Terry Smith, Kenneth B. McCredie, Emil J. Freireich	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact